Diane Frankle represents publicly traded and privately held companies engaged in a wide variety of US and cross-border mergers, acquisitions, strategic alliances and joint ventures. Diane has completed more than 100 M&A deals with a total value exceeding $12 billion during the last 25 years. Her focus clients include companies in the technology, life sciences and health care industries, including those in software, internet security, storage, biotech, medical device, semiconductor, pharmaceutical and other sectors.
Diane also regularly advises boards of directors and board committees on fiduciary duties, corporate governance and disclosure issues, crisis management and internal investigations. In addition, she represents public companies and management on executive compensation issues, and she also represents companies in public and private offerings of equity.